We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
-8.73%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$308M
AUM Growth
-$44.2M
Cap. Flow
-$4.71M
Cap. Flow %
-1.53%
Top 10 Hldgs %
25.53%
Holding
393
New
63
Increased
64
Reduced
89
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.58M
2
CAG icon
Conagra Brands
CAG
+$6.41M
3
GIS icon
General Mills
GIS
+$6.28M
4
BDX icon
Becton Dickinson
BDX
+$6.25M
5
PG icon
Procter & Gamble
PG
+$6.16M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$8.69M
2
ZBRA icon
Zebra Technologies
ZBRA
+$8.06M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$7.68M
4
MCO icon
Moody's
MCO
+$7.1M
5
ZTS icon
Zoetis
ZTS
+$6.57M

Sector Composition

Rank Sector Weight
1 Healthcare 18.62%
2 Financials 14.7%
3 Energy 12.88%
4 Consumer Staples 11.59%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCKT icon
201
Hackett Group
HCKT
$287M
$154K 0.05%
8,108
– –
THD icon
202
iShares MSCI Thailand ETF
THD
$357M
$154K 0.05%
+2,231
New +$164K
EZA icon
203
iShares MSCI South Africa ETF
EZA
$578M
$152K 0.05%
3,589
+20
+0.6% +$948
EPU icon
204
iShares MSCI Peru and Global Exposure ETF
EPU
$558M
$146K 0.05%
+5,738
New +$178K
VRE
205
DELISTED
Veris Residential
VRE
$142K 0.05%
10,697
– –
OII icon
206
Oceaneering
OII
$4.77B
$138K 0.04%
12,891
– –
BP icon
207
BP
BP
$107B
$132K 0.04%
4,642
-63
-1% -$1.93K
XOM icon
208
ExxonMobil
XOM
$634B
$128K 0.04%
1,495
– –
ANET icon
209
Arista Networks
ANET
$238B
$125K 0.04%
5,344
-5,612
-51% -$154K
SCHM icon
210
Schwab US Mid-Cap ETF
SCHM
$15.1B
$121K 0.04%
5,796
+594
+11% +$13.7K
DIS icon
211
Walt Disney
DIS
$181B
$120K 0.04%
1,270
– –
SHEL icon
212
Shell
SHEL
$245B
$114K 0.04%
+2,174
New +$122K
OXY icon
213
Occidental Petroleum
OXY
$55.9B
$110K 0.04%
1,875
– –
MDY icon
214
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$109K 0.04%
264
+17
+7% +$7.68K
SBUX icon
215
Starbucks
SBUX
$120B
$106K 0.03%
1,390
– –
BA icon
216
Boeing
BA
$185B
$96K 0.03%
705
-25,508
-97% -$3.76M
RY icon
217
Royal Bank of Canada
RY
$293B
$95K 0.03%
980
-11
-1% -$1.13K
GSK icon
218
GSK
GSK
$106B
$94K 0.03%
1,732
-16
-0.9% -$883
BMO icon
219
Bank of Montreal
BMO
$127B
$92K 0.03%
956
-12
-1% -$1.27K
DEO icon
220
Diageo
DEO
$53.6B
$89K 0.03%
513
-1
-0.2% -$190
AMX icon
221
America Movil
AMX
$71.2B
$87K 0.03%
+4,256
New +$87.5K
SCHP icon
222
Schwab US TIPS ETF
SCHP
$16.2B
$86K 0.03%
3,070
– –
AEG icon
223
Aegon
AEG
$14.1B
$85K 0.03%
19,976
-681
-3% -$3.38K
VOD icon
224
Vodafone
VOD
$37.4B
$84K 0.03%
5,364
+5,355
+59,500% +$85.5K
ADI icon
225
Analog Devices
ADI
$190B
$83K 0.03%
566
-70
-11% -$11K
7 8
9
10 11

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Contravisory Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Contravisory Investment Management held 393 positions worth $308M, down 13% from $352M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Contravisory Investment Management's Q2 2022 filing shows 63 new, 64 increased, 89 reduced and 70 closed positions. Its largest new stake was Conagra Brands: 188,092 shares worth $6.44M. The largest sale was Accenture, an estimated $8.69M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Energy.

  • Contravisory Investment Management's largest Q2 2022 buy was Conagra Brands: 188,092 shares worth $6.44M.
  • Contravisory Investment Management added most to Merck in Q2 2022, an estimated $6.58M increase.
  • Contravisory Investment Management's biggest Q2 2022 reduction was Accenture, cutting an estimated $8.69M.
  • Contravisory Investment Management fully exited Zebra Technologies in Q2 2022, selling an estimated $8.06M.
  • Contravisory Investment Management's ten largest holdings make up 26% of its $308M portfolio in Q2 2022.
  • Contravisory Investment Management opened 63 new positions and closed 70 in Q2 2022.
  • Contravisory Investment Management's portfolio value fell 13% quarter-over-quarter to $308M.

Based on Contravisory Investment Management's 13F filing for Q2 2022, filed 13 Jul 2022.